Is the Problem With Nike's Stock That It Has Too Much Exposure to China?

Greater China revenue fell 7% y/y (10% decline excluding FX) in Nike's most recent quarter; Greater China represents ~14% of company revenue. Overall sales were flat, North America was +3%, and Nike has seen a ~70% decline in its stock over five years and an additional ~30% drop year-to-date, recently hitting a 52-week low. Management under CEO Elliott Hill is pursuing a turnaround amid significant China exposure in both sales and manufacturing, raising geopolitical and supply-chain risks for investors.

Analysis

Nike’s China pain is not just a regional revenue problem — it propagates through margins, channel economics, and global supply chains. Expect a 2–3 quarter rhythm of wholesale destocking and promotional activity that will compress gross margins by high-single to low-double percentage points unless inventory flow normalizes; that margin pressure will show up before top-line stabilization and will be the primary driver of any near-term downside in the stock.

Second-order winners are Southeast Asian footwear manufacturers and local sportswear brands that can accelerate capacity and take share on price and speed-to-market; second-order losers include branded wholesale partners and premium-price product tiers where elasticity is high. Currency moves and geopolitical policy shifts create a volatility corridor for NKE: RMB weakness or new restrictions on US-China commerce can both accelerate margin erosion or force a more rapid supply-chain re-shoring that increases unit costs by a mid-single-digit percentage over 12–24 months.

The catalyst calendar is straightforward: FX and guidance around the next two fiscal quarters (60–180 days) will set the immediate path, while a strategic pivot (manufacturing footprints, DTC localization, or licensing deals) would be a 6–24 month inflection. The consensus narrative underweights brand durability and the option value of a faster DTC + product localization play; if management executes a credible China mitigation plan and inventory normalizes, recovery could be sharp and binary within 12 months, but that is a low-probability event today and should be traded, not bought outright.

Key Decisions for Investors

• Short NKE via a 3–6 month bearish put spread (buy 25% OTM put / sell 15% OTM put). Rationale: capitalizes on continued margin and channel weakness with limited capital at risk; reward profile becomes attractive if NKE moves down ~15–25% in the window. Max loss = premium paid; target return 2–4x if downside materializes.
• Pair trade — short NKE stock (or short-dated calls) funded by long NVDA 12-month calls (buy 1 NVDA 12-month ATM call per $1 of short NKE notional). Rationale: rotate from slow-growth, China-exposed consumer to secular AI growth. Risk: NKE rebound or broad market selloff; reward: uncapped NVDA upside offsets equity decline and benefits from re-rating dynamics over 6–12 months.
• Long INTC 9–12 month call spread (buy near-ATM call / sell 30% OTM call). Rationale: asymmetric, limited-risk play on industrial/AI capex catching up and potential share gains if fabs or packaging wins accelerate. Expect outcome in 6–12 months; max loss = debit, target 2–3x if execution/procurement cycles accelerate.
• Hedge consumer-China exposure with long NFLX 3–9 month calls or equity: use a small long NFLX position as a macro hedge to benefit from US consumer resilience and reallocation of passive capital into growth. Timeframe 3–9 months; risk: domestic slowdown or subscriber miss; reward: >1x upside if sentiment rotation continues.